Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Karyopharm Therapeutics Inc. (KPTI) had Cash Flow from Financial Activities of $48.90M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$33.43M |
|
$-67.02M |
|
$1.08M |
|
$32.35M |
|
$55.96M |
|
$-22.53M |
|
$-44.50M |
|
$-67.02M |
|
$-67.02M |
|
$-67.02M |
|
$-67.02M |
|
$-67.02M |
|
$-67.02M |
|
$-22.53M |
|
$-20.06M |
|
28.94M |
|
28.94M |
|
$-2.32 |
|
$-2.32 |
|
| Balance Sheet Financials | |
$106.38M |
|
$0.09M |
|
$4.94M |
|
$111.32M |
|
$134.23M |
|
$209.63M |
|
$307.25M |
|
$441.49M |
|
$-330.17M |
|
$-330.17M |
|
$-330.17M |
|
22.68M |
|
| Cash Flow Statement Financials | |
$-47.66M |
|
$-6.84M |
|
|
Cash Flow from Financial Activities |
$48.90M |
$60.89M |
|
$55.30M |
|
$-5.59M |
|
$4.94M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.79 |
|
-- |
|
-- |
|
-1.74 |
|
-0.76 |
|
96.75% |
|
-67.38% |
|
-67.38% |
|
-- |
|
-200.48% |
|
-200.48% |
|
$-47.66M |
|
-- |
|
-- |
|
-- |
|
0.30 |
|
0.27 |
|
1.12 |
|
80.41 |
|
20.30% |
|
20.30% |
|
-60.21% |
|
55.61% |
|
$-14.56 |
|
$-1.65 |
|
$-1.65 |
|